These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9657584)
1. Airway response of children with primary ciliary dyskinesia to exercise and beta2-agonist challenge. Phillips GE; Thomas S; Heather S; Bush A Eur Respir J; 1998 Jun; 11(6):1389-91. PubMed ID: 9657584 [TBL] [Abstract][Full Text] [Related]
2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ; Winter TH; Aalbers R Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [TBL] [Abstract][Full Text] [Related]
3. The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia. Koh YY; Park Y; Jeong JH; Kim CK; Min YG; Chi JG Chest; 2000 Feb; 117(2):427-33. PubMed ID: 10669686 [TBL] [Abstract][Full Text] [Related]
4. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
5. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Inman MD; O'Byrne PM Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164 [TBL] [Abstract][Full Text] [Related]
6. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246 [TBL] [Abstract][Full Text] [Related]
7. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM; Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895 [TBL] [Abstract][Full Text] [Related]
8. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline. Richter K; Janicki S; Jörres RA; Magnussen H Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726 [TBL] [Abstract][Full Text] [Related]
9. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Carlsen KH; Røksund O; Olsholt K; Njå F; Leegaard J; Bratten G Eur Respir J; 1995 Nov; 8(11):1852-5. PubMed ID: 8620951 [TBL] [Abstract][Full Text] [Related]
10. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma. Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010 [TBL] [Abstract][Full Text] [Related]
11. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol. Steffensen I; Faurschou P; Riska H; Rostrup J; Wegener T Allergy; 1995 Aug; 50(8):657-63. PubMed ID: 7503401 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Ellerman A; Bisgaard H Eur Respir J; 1997 Oct; 10(10):2376-9. PubMed ID: 9387968 [TBL] [Abstract][Full Text] [Related]
13. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates. Newhouse MT; Nantel NP; Chambers CB; Pratt B; Parry-Billings M Chest; 1999 Apr; 115(4):952-6. PubMed ID: 10208191 [TBL] [Abstract][Full Text] [Related]
14. Mucociliary clearance in COPD can be increased by both a D2/beta2 and a standard beta2 agonists. Hasani A; Toms N; Agnew JE; Lloyd J; Dilworth JP Respir Med; 2005 Feb; 99(2):145-51. PubMed ID: 15715181 [TBL] [Abstract][Full Text] [Related]
15. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Belman MJ; Botnick WC; Shin JW Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581 [TBL] [Abstract][Full Text] [Related]
16. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. van Essen-Zandvliet EE; Hughes MD; Waalkens HJ; Duiverman EJ; Pocock SJ; Kerrebijn KF Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640 [TBL] [Abstract][Full Text] [Related]
17. Effects of exercise and beta 2-agonists on lung function in chronic obstructive pulmonary disease. Corsico A; Fulgoni P; Beccaria M; Zoia MC; Barisione G; Pellegrino R; Brusasco V; Cerveri I J Appl Physiol (1985); 2002 Dec; 93(6):2053-8. PubMed ID: 12391117 [TBL] [Abstract][Full Text] [Related]
18. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I; Hall IP; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [TBL] [Abstract][Full Text] [Related]
19. Do pulmonary and extrapulmonary features differ among cystic fibrosis, primary ciliary dyskinesia, and healthy children? Denizoglu Kulli H; Gurses HN; Zeren M; Ucgun H; Cakir E Pediatr Pulmonol; 2020 Nov; 55(11):3067-3073. PubMed ID: 32877003 [TBL] [Abstract][Full Text] [Related]
20. A study with cumulative doses of formoterol and salbutamol in children with asthma. Foucard T; Lönnerholm G Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]